About Reproductive Medicine Network

What is the Reproductive Medicine Network?

The History of the Reproductive Medicine Network

Disorders of the reproductive system in both women and men have both a public health and economic impact. For those people who are dealing with infertility issues, the out of pocket cost can be astronomical. Treatment for reproductive system disorders s uch as endometriosis or fibroids may result in the loss of childbearing potential. Relatively few interventions and treatments for these disorders have been subjected to rigorous scientific evaluation.

The long-term objective of the Reproductive Medicine Network is to improve the care of women and men with disorders affecting the reproductive system by conducting controlled clinical trials of selected diagnostic and therapeutic interventions. Funding for this research is provided by the National Institutes of Health through the National Institute of Child Health and Human Development.

There are eight research centers located across the United States. Yale Collaborative Center for Statistics in Science (C2S2), New Haven, Connecticut, coordinates the clinical trials for the Reproductive Medicine Network. At this time, protocols are being developed. For more information about our studies go to the RMN trials in Active Studies.

For more information visit the NICHD section on Reproductive Medicine.